NASDAQ:EKSO
Ekso Bionics Holdings Stock News
$1.42
-0.0700 (-4.70%)
At Close: Mar 27, 2024
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
04:05pm, Tuesday, 06'th Sep 2022
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics: Fragile Opportunity
04:34am, Wednesday, 24'th Aug 2022
Ekso Bionics has added a new use case for the EksoNR exoskeleton, multiple sclerosis, opening some new avenues for marginal revenue growth. Pre-Covid, Ekso had started to see sharp improvements in ope
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q2 2022 Results - Earnings Call Transcript
07:53pm, Thursday, 28'th Jul 2022
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q2 2022 Results Conference Call July 28, 2022 4:30 PM ET Company Participants David Carey - Head, Investor Relations Steven Sherman - Chairman & CEO Scott Da
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
06:44pm, Thursday, 28'th Jul 2022
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
08:00am, Thursday, 21'st Jul 2022
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today a
Ekso Bionics (EKSO) Could Find Support Soon, Here's Why You Should Buy the Stock Now
01:55pm, Friday, 13'th May 2022 Zacks Investment Research
Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among W
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates
09:35pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics Reports First Quarter 2022 Results
08:05pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates
06:48pm, Thursday, 28'th Apr 2022
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SARTORIUS (SARTF) Tops Q1 Earnings and Revenue Estimates
02:25pm, Thursday, 21'st Apr 2022 Zacks Investment Research
SARTORIUS (SARTF) delivered earnings and revenue surprises of 10.04% and 8.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
12:03pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
08:03am, Thursday, 21'st Apr 2022
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q4 2021 Results - Earnings Call Transcript
04:06am, Friday, 25'th Feb 2022 Seeking AlphaEkso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q4 2021 Results - Earnings Call Transcript
11:06pm, Thursday, 24'th Feb 2022
Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q4 2021 Results - Earnings Call Transcript
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
11:00pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?